Filing Details
- Accession Number:
- 0001012975-15-000684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-25 16:38:50
- Reporting Period:
- 2015-09-24
- Filing Date:
- 2015-09-25
- Accepted Time:
- 2015-09-25 16:38:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1374690 | Zafgen Inc. | ZFGN | Pharmaceutical Preparations (2834) | 203857670 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192603 | P Kevin Starr | C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-24 | 1,655,095 | $0.00 | 346,950 | No | 4 | J | Indirect | See footnote |
Common Stock | Disposition | 2015-09-24 | 74,949 | $43.73 | 272,001 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2015-09-24 | 61,630 | $44.10 | 210,371 | No | 4 | S | Indirect | See footnote |
Common Stock | Acquisiton | 2015-09-24 | 476,170 | $0.00 | 476,170 | No | 4 | J | Indirect | See footnote |
Common Stock | Disposition | 2015-09-24 | 476,170 | $0.00 | 0 | No | 4 | J | Indirect | See footnote |
Common Stock | Acquisiton | 2015-09-24 | 98,834 | $0.00 | 370,323 | No | 4 | J | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | J | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | J | Indirect | See footnote |
No | 4 | J | Indirect | See footnote |
No | 4 | J | Direct |
Footnotes
- Distribution of shares in kind by Third Rock Ventures, L.P. ("TRV") on a pro rata basis to its partners.
- The shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC") and the Reporting Person is a Manager of TRV GP LLC, as such, each of TRV GP and TRV GP LLC, the other Managers of TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
- The shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC") and the Reporting Person is a Manager of TRV GP LLC, as such, each of TRV GP and TRV GP LLC, the other Managers of TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.48, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- TRV GP received shares distributed in kind by TRV on a pro rata basis to its partners.
- The shares are directly held by TRV GP. As such, each of TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV GP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
- Distribution of shares in kind by TRV GP on a pro rata basis to its partners.
- The Reporting Person received shares distributed in kind by TRV GP on a pro rata basis to its partners.